Awards
| Award From | Category | Type | Award | Year Sort descending | Center(s) | Applications | Description |
|---|---|---|---|---|---|---|---|
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | State and Local Economic Development Award | Chief Science Officer (CSO) Development Training Certificate Program Team “CSO Boot Camp” | 2012 | OD | Research Materials | In the Mid-Atlantic Region, Maryland is in an enviable position with regard to biotechnology-related resources that encourage and support entrepreneurial efforts. Academic institutions, a federal laboratory, a committed county department of economic development, and a unique small business have… |
Federal Laboratory Consortium (FLC) |
National Award | Excellence in Technology Transfer | An Interactive Software Package for the Analysis of Microarray Data | 2012 | NCI, OD | Software / Apps | The emergence of bioinformatics tools, which integrate molecular biology and genomics with computer based information technology, is bringing about a revolution in our understanding of the molecular mechanisms underlying normal and dysfunctional biological processes. The microarray is one such tool… |
Federal Laboratory Consortium (FLC) |
National Award | Excellence in Technology Transfer | Development of Eribulin, a Potent Anti-Cancer Agent from a Marine Sponge | 2012 | NCI | Therapeutics | Natural products have formed the basis of traditional medicine systems for thousands of years and have been the single most productive source of leads for the development of cancer drugs. This nomination describes the discovery of halichondrin B, a compound isolated from a species of marine sponge… |
Federal Laboratory Consortium (FLC) |
National Award | Excellence in Technology Transfer | Use of Therapeutic Antibodies as a Novel Treatment for Multiple Sclerosis | 2012 | NINDS, NCI, OD | Therapeutics | Multiple sclerosis (MS) is a disease of the central nervous system in which the immune system attacks the brain and spinal cord, typically resulting in muscle weakness, problems with vision and coordination, pain, and in some patients, cognitive impairments. The disorder affects approximately 400,… |
Federal Laboratory Consortium (FLC) |
National Award | Excellence in Technology Transfer | Vibro-Tactile Stimulation Device and Method for Swallowing Disorder | 2012 | NINDS, OD | Medical Devices | The transferred technology is a non-invasive, intensive, swallowing retraining device that combines sensory stimulation with motor retraining to rehabilitate swallow function, initially targeted for dysphagia patients. Dysphagia is a common disorder that creates difficulty swallowing. Patients at… |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Excellence in Technology Transfer | Use of Therapeutic Antibodies as a Novel Treatment for Multiple Sclerosis | 2011 | NINDS, NCI, OD | Therapeutics | Multiple sclerosis (MS) is a disease of the central nervous system in which the immune system attacks the brain and spinal cord, typically resulting in muscle weakness, problems with vision and coordination, pain, and, in some patients, cognitive impairments. The disorder affects approximately 400,… |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Outstanding Technology Transfer Professional | Laurie Arrants - Director, Technology Transfer Office, NINDS | 2011 | As Director of the Technology Transfer Office at the National Institutes of Health’s (NIH) National Institute of Neurological Disorders and Stroke (NINDS), Laurie Arrants has provided the leadership and vision that have been instrumental in facilitating transfer of the innovative research carried… | ||
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | State and Local Economic Development Award | National Cancer Institute | 2011 | NCI, OD | The Mid-Atlantic Region State and Local Economic Development Award recognizes successful initiatives that involve partnership between state or local economic development groups and federal laboratories for economic benefit in the region. The FLC Mid-Atlantic Region (FLC-MAR) has actively… | |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Outstanding Technology Transfer Professional | Dr. Samuel Bish - Licensing and Patenting Manager, NIH Office of Technology Transfer | 2011 | OD | Technology Transfer Professional Rookie of the YearThe structure and function of the Office of Technology Transfer (OTT) at the National Institutes of Health (NIH) require new Licensing and patenting managers to be involved in all aspects of technology transfer, specifically technology valuation,… | |
Federal Laboratory Consortium (FLC) |
National Award | Excellence in Technology Transfer | A Lifesaving Diagnostic Test for Cancer Patients | 2011 | NCI, OD | Diagnostics | Most people are aware that anti-cancer treatments often have negative side effects, but patients are willing to tolerate these side effects for the potential life-saving effects of the treatment. However, some patients treated with the anti-cancer drug 5-Fluorouracil (5-FU) will have fatal… |
Federal Laboratory Consortium (FLC) |
National Award | STEM Award | 2010 STEM Postdoc Conference Committee | 2011 | NIAAA, OD | The STEM Award recognizes the efforts of an FLC laboratory employee or team that has demonstrated outstanding work in support of science, technology, engineering, and mathematics (STEM) education during the past year. The annual STEM Postdoc Conference and Career Fair matches Washington, D.C.… | |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Excellence in Technology Transfer | A Life-Saving Diagnostic Test for Cancer Patients | 2010 | NCI | Diagnostics | Most people are aware that anti-cancer treatments often have negative side effects, but patients are willing to tolerate these side effects for the potential life-saving effects of the treatment. However, some patients treated with the anti-cancer drug 5-Fluorouracil (5-FU) will have fatal… |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Excellence in Technology Transfer | High-Speed Counter Current Chromatography | 2010 | NHLBI | Non-Medical Devices | The pool of potential medicinal candidates found in natural products is vast. One section of one plant can contain thousands of potential candidate compounds. Natural products research has become increasingly interesting to pharmaceutical companies engaged in new drug discovery. As a result, a… |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Excellence in Technology Transfer | Identification and Development of Agents to Treat Glioblastoma and Other Tumors Over-expressing Nuclear Receptor CoRepressor | 2010 | NINDS | Therapeutics | The National Institute of Neurological Disorders and Stroke (NINDS) and Lixte Biotechnology Holdings, Inc. (Lixte) are collaborating to identify and develop agents that target the Nuclear Receptor CoRepressor (N-COR) pathway. Dr. Zhengping Zhuang’s laboratory at NINDS has determined that several… |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Excellence in Technology Transfer | Novel Protein-Like Therapeutics for Treatment of Cancer | 2010 | NCI | Therapeutics | Cancer is caused by the improper regulation of cascading signals, or pathways, within the cell. One of the most prevalent means of fighting cancer involves the development of small molecule drugs and biologics that target and bind various proteins to disrupt certain pathways. The Hedgehog pathway… |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Excellence in Technology Transfer | Therapeutic Antibodies for the Treatment of Cancer | 2010 | NCI | Therapeutics | The term “cancer” is used to describe a collection of several diseases that are caused by the aberrant growth of cells and the invasion of these cells into other tissues, where they disrupt normal organ function. Cancers are commonly treated by surgical removal of the cancerous tissue, followed by… |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Excellence in Technology Transfer | Therapeutic Immunotoxins for the Treatment of T Cell Malignancies | 2010 | NIMH, OD | Therapeutics | Abnormal T lymphocyte (T cell) function, including tumor formation in T cells, can lead to a wide variety of diseases. Over 100 million people worldwide suffer from T cell autoimmune disorders of varying severity, such as lupus and graft-versus-host disease, and the incidence of T cell-mediated… |
Federal Laboratory Consortium (FLC) |
National Award | Excellence in Technology Transfer | Cell Line Bank for Cancer Research | 2010 | NCI | Research Materials | Cell lines are important biomedical tools that have revolutionized the way researchers study diseases. Human tumor cell lines can be used as in vitro model systems of cancer that are able to simulate how the disease behaves in the body. The National Cancer Institute (NCI) has approximately 439… |
Federal Laboratory Consortium (FLC) |
National Award | Excellence in Technology Transfer | Innovative Techniques and Reagents for Improved Genetic Engineering | 2010 | NCI | Research Materials | The development of restriction enzyme technology in the 1970s was a breakthrough in genetic engineering. For the first time, scientists were able to cut DNA at specific sites and insert sequences with matching ends. However, the technology was limited to insertion at particular sites in the host… |
Federal Laboratory Consortium (FLC) |
National Award | Excellence in Technology Transfer | PROSTVAC, a Therapeutic Vaccine for Treating Prostate Cancer | 2010 | NCI | Vaccines | Prostate cancer is the most common non-skin cancer of males in the U.S., and is responsible for more deaths than any other cancer, except lung cancer. Cancer vaccines, which harness the body’s immune system to identify and destroy cancer cells, have emerged as a promising new approach to fighting… |
Federal Laboratory Consortium (FLC) |
National Award | Laboratory Director of the Year | Dr. Robert Wiltrout - Director, Center for Cancer Research, National Cancer Institute | 2010 | NCI | Dr. Robert Wiltrout is Director of the National Cancer Institute’s (NCI) Center for Cancer Research (CCR), which is home to more than 250 scientists and clinicians conducting intramural research at NCI. The Center is organized into over 50 branches and laboratories, each grouping scientists with… | |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Excellence in Technology Transfer | Cell Line Bank for Cancer Research | 2009 | NCI | Research Materials | Cell lines are important biomedical tools that have revolutionized the way in which researchers study diseases. Human tumor cell lines can be used as in vitro model systems of cancer that are able to simulate the manner in which the disease behaves in the body. This technology describes… |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Excellence in Technology Transfer | Innovative Techniques and Reagents for Improved Genetic Engineering | 2009 | NCI | Research Materials | The development of restriction enzyme technology in the 1970s was a breakthrough in molecular biology research. For the first time, scientists were able to cut DNA at specific sites, and insert sequences with matching ends. However, the technology was limited to insertion at particular sites in the… |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Laboratory Director of the Year | Dr. Robert Wiltrout - Director, Center for Cancer Research, National Cancer Institute | 2009 | NCI | Over the past 29 years, Dr. Wiltrout has contributed as a scientist and leader to the Center for Cancer Research by supporting the infrastructure necessary to ensure continued new and creative collaborations that result in successful technology development and transfer to the Center’s industrial… | |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Outstanding Technology Transfer Professional | Karen Maurey - Director, Technology Transfer Center, National Cancer Institute | 2009 | NCI | As Director of the Technology Transfer Center (TTC) at the NIH National Cancer Institute (NCI), Karen Maurey has provided the leadership and vision that has been instrumental in facilitating the transfer of the innovative research carried out by the NCI scientists to industrial partners and… |